Use of amphiphilic nucleoside phosphonoformic acid...

Details Use of amphiphilic nucleoside phosphonoformic acid... Use of amphiphilic nucleoside phosphonoformic acid...

2007-10-09

2007-10-09

Lewis, Patrick (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S042000, C514S043000, C514S045000, C514S050000, C514S052000

Reexamination Certificate

active

11015209

ABSTRACT:
The invention relates to a method for treating infectious diseases which are elicited by viruses which are pathogenic to humans comprising the step of administering an amphiphilic nucleoside-phosphonoformic acid derivative having an esterified or unesterified carboxyl group, preferably of a nucleoside-glycerol-(hydroxycarbonyl)-phosphonate, as an active compound.

REFERENCES:
patent: 5679652 (1997-10-01), Schott
patent: 6787525 (2004-09-01), Schott et al.
patent: 42 24 878 (1994-02-01), None
patent: WO-98/38202 (1998-09-01), None
patent: WO-00/34298 (2000-06-01), None
Crumpacker, New England J. of Medicine (1998) 335:721-731.
Eckle et al., Blood (2000) 96(9):3286-3289.
International Search Report for PCT/EP03/006012, mailed on Oct. 15, 2003, 3 pages.
Prix et al., Journal of Clinical Virology (1998) 11:29-37.
Prix et al., Journal of Infectious Diseases (1999) 180:491-495.

Affiliated with

Also associated with

Rating

Use of amphiphilic nucleoside phosphonoformic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of amphiphilic nucleoside phosphonoformic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of amphiphilic nucleoside phosphonoformic acid... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3858817